aim
work
better
understand
misclassif
error
identif
true
case
studi
impact
error
epidem
curv
examin
public
avail
timeseri
data
laboratori
test
viral
infect
causal
agent
tri
explor
use
bayesian
approach
sensit
specif
pcrbase
diagnost
test
data
origin
alberta
canada
avail
citi
philadelphia
usa
avail
analysi
reveal
data
compat
nearperfect
specif
challeng
gain
inform
sensit
prior
posterior
larg
overlap
appli
insight
uncertaintybia
analysi
epidem
curv
jurisdict
assumpt
improv
degrad
sensit
sensit
improv
observ
adjust
epidem
curv
like
fall
within
confid
interv
observ
count
howev
bia
shape
peak
epidem
curv
pronounc
sensit
either
degrad
remain
poor
rang
extrem
scenario
hundr
undiagnos
case
even
among
test
possibl
potenti
lead
uncheck
contagion
case
selfisol
best
way
better
understand
bia
epidem
curv
due
error
test
empir
evalu
misclassif
diagnosi
clinic
set
appli
knowledg
adjust
epidem
curv
task
bayesian
method
present
wellsuit
well
known
outcom
misclassif
bia
epidemiolog
result
yet
infrequ
quantifi
adjust
result
context
infecti
diseas
outbreak
pandem
fals
posit
diagnos
may
lead
wast
limit
resourc
test
kit
hospit
bed
absenc
healthcar
workforc
hand
fals
neg
diagnos
contribut
uncontrol
spread
contagion
case
selfisol
ongo
epidem
test
sensit
sn
specif
sp
case
ascertain
fix
preval
outcom
infect
determin
whether
fals
posit
neg
domin
goldstein
burstyn
show
suboptim
test
sn
despit
excel
sp
result
overestim
case
earli
stage
outbreak
substanti
underestim
case
preval
increas
level
seen
time
write
howev
understand
true
scope
pandem
depend
precis
insight
accuraci
laboratori
test
use
case
confirm
undiagnos
case
particular
concern
aris
untest
person
may
may
symptom
underascertain
error
test
among
select
test
inconclus
result
focu
misclassifi
patient
due
error
test
perform
accord
world
health
organ
case
definit
may
deem
probabl
case
test
result
inconclus
present
accuraci
test
viral
infect
causal
agent
unknown
canada
usa
global
report
sp
exce
sn
scienc
report
diagnost
fang
et
al
ai
et
al
typic
scenario
clinic
laboratori
valid
studi
need
fulli
quantifi
perform
diagnost
assay
measur
sn
sp
howev
pandem
limit
resourc
like
alloc
test
manag
patient
rather
perform
valid
work
imperfect
test
still
shed
crude
light
scope
public
health
emerg
inde
count
observ
posit
neg
test
inform
sn
sp
certain
combin
paramet
far
like
compat
data
reason
assert
true
posit
test
gener
sever
case
diseas
expect
onset
outbreak
reflect
test
sampl
strong
clinic
suspicion
test
produc
higher
likelihood
diseas
overal
preval
popul
would
remain
low
outbreak
progress
public
awar
consequ
symptomat
asymptomat
peopl
test
overal
preval
diseas
expect
rapidli
increas
sever
diseas
popul
level
temper
reason
expect
inde
report
anecdot
earli
outbreak
laboratori
test
inaccur
viru
uniqu
identifi
featur
exploit
test
uncertain
laboratori
procedur
contain
error
ahead
standard
regulatori
approv
anecdot
sn
suppos
wors
sp
congruent
report
earli
diagnost
test
china
fang
et
al
ai
et
al
sn
sp
improv
laboratori
around
world
rush
perfect
test
konrad
et
al
us
fda
corman
et
al
approach
perform
test
similar
virus
eg
binsae
et
al
merckx
et
al
use
publicli
avail
timeseri
data
laboratori
test
result
prior
knowledg
infecti
diseas
outbreak
may
abl
gain
insight
true
accuraci
diagnost
assay
thu
pursu
two
specif
aim
develop
bayesian
method
attempt
learn
publicli
avail
timeseri
test
sn
sp
laboratori
test
b
conduct
mont
carlo
probabilist
sensit
analysi
impact
plausibl
extent
misclassif
bia
epidem
curv
data
method
access
http
data
also
display
appendix
digit
data
releas
canadian
provinc
alberta
figur
peopl
test
alberta
day
http
laboratori
test
tab
sampl
eg
nasopharyng
np
swab
bronchial
wash
undergo
nucleic
acid
test
nat
use
primersprob
target
e
envelop
protein
corman
et
al
nd
rdrp
rnadepend
rna
polymeras
qualit
detect
method
develop
provlab
alberta
gene
viru
data
digit
shown
tabl
appendix
relev
data
note
reproduc
full
data
sourc
provinci
surveil
inform
system
psi
laboratori
surveil
system
receiv
posit
result
notifi
diseas
diseas
laboratori
surveil
alberta
precis
lab
apl
system
also
receiv
neg
result
subset
organ
disclaim
content
format
report
subject
chang
case
investig
number
may
fluctuat
case
resolv
data
includ
interact
data
applic
uptod
midday
date
post
data
citi
philadelphia
obtain
http
indic
test
result
might
take
sever
day
process
test
pcrbase
sampl
collect
np
swab
perform
one
three
lab
state
public
health
labcorp
quest
addit
hospit
perform
test
use
inhous
pcr
method
percept
empir
data
avail
us
sn
around
report
fals
neg
base
clinic
featur
patient
consist
diseas
issu
aris
problem
specimen
collect
time
collect
addit
test
perform
characterist
data
digit
shown
tabl
appendix
brief
descript
model
strategi
follow
full
detail
appendix
b
preval
infect
test
pool
test
sensit
model
piecewiselinear
small
number
adjac
time
interv
day
four
interv
equal
width
exampl
interv
endpoint
refer
knot
henc
five
knot
exampl
prior
distribut
preval
construct
specifi
lower
upper
bound
preval
knot
uniform
distribut
bound
prior
distribut
sensit
construct
similarli
modif
encourag
smooth
variat
time
see
appendix
b
full
detail
test
specif
consid
constant
time
uniform
prior
distribut
specifi
lower
upper
bound
specif
posterior
distribut
ensu
unknown
paramet
latent
variabl
given
observ
data
ie
given
daili
count
neg
posit
test
result
distribut
describ
knowledg
preval
sensit
specif
timeseri
latent
number
truli
posit
among
test
tth
day
thu
learn
posterior
distribut
timeseri
give
adjust
seri
number
true
posit
test
pool
along
indic
uncertainti
discuss
length
appendix
b
model
formul
neither
rule
rule
learn
test
sensit
specif
report
data
particularli
high
specif
regim
problem
separ
infect
preval
test
sensit
mathemat
challeng
data
directli
inform
product
preval
sensit
tri
separ
two
regard
statist
unidentifi
problem
mathematician
might
speak
illpos
invers
problem
engin
might
refer
blind
sourc
separ
challeng
howev
circumst
might
amen
degre
separ
particular
piecewiselinear
structur
sensit
preval
strong
quadrat
pattern
observ
data
present
could
particularli
help
guid
separ
hand
littl
separ
achiev
analysi
natur
revert
back
sensit
analysi
priori
uncertainti
test
sensit
infect
preval
acknowledg
reliabl
pcrbase
assay
achiev
nearperfect
sp
sn
around
konrad
et
al
us
fda
corman
et
al
scienc
report
diagnost
howev
earli
outbreak
problem
sensit
diagnost
test
wide
report
owe
specimen
collect
reagent
prepar
quantifi
base
report
posit
lower
bound
prior
sn
upper
bound
expect
sp
high
select
timeinvari
prior
uniform
bound
preval
testposit
sampl
like
chang
time
well
exampl
due
priorit
test
base
age
occup
morbid
cdc
difficult
quantifi
would
differ
popul
preval
infect
yield
random
sampl
govern
known
popul
dynam
model
consequ
adopt
flexibl
datadriven
approach
allow
preval
chang
within
broad
rang
see
appendix
b
next
examin
much
could
learnt
epidem
curv
knew
sensit
laboratori
test
appli
insight
plausibl
extent
sensit
specif
recalcul
epidem
curv
alberta
canada
data
observ
count
versu
presum
incid
date
date
report
alberta
health
obtain
figur
case
alberta
day
post
http
case
count
tab
count
case
shown
tabl
c
match
date
date
laboratori
test
also
repeat
calcul
data
avail
citi
philadelphia
strong
assumpt
date
test
date
onset
ie
c
remov
march
count
report
delay
sever
day
laboratori
test
observ
count
incid
case
c
estim
true
count
c
c
assumpt
specif
indistinguish
perfect
consid
situat
time
trend
line
find
well
sensit
either
improv
realist
best
case
degrad
pessimist
worst
case
simul
variou
valu
use
beta
distribut
rang
mean
fix
standard
deviat
paramet
set
use
http
appar
epidem
curv
gener
manner
higher
count
observ
curv
main
interest
illustr
much
underestim
bia
depict
uncertaintybia
analysi
reflect
systemat
error
illustr
purpos
common
assumpt
experi
dwarf
random
error
comput
code
r
r
core
team
uncertainti
analysi
appendix
c
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
jurisdict
evid
nonlinear
observ
proport
posit
test
figur
justifi
flexibl
approach
variat
sensit
preval
manifest
quadrat
pattern
observ
preval
knot
data
jurisdict
consist
hypothesi
number
truli
infect
underestim
even
though
observ
count
tend
fall
within
credibl
interv
posterior
distribut
count
true
posit
test
figur
b
underdiagnosi
pronounc
posit
case
preval
posit
test
higher
ie
philadelphia
relat
alberta
philadelphia
posterior
preval
posit
test
day
late
march
alberta
median
posterior
preval
posit
test
day
late
march
surpris
number
fals
neg
proport
observ
case
sensit
specif
appear
high
enough
observ
preval
posterior
distribut
indistinguish
prior
still
left
impress
sensit
test
anywher
center
around
one
specul
departur
posterior
distribut
uniform
prior
given
posterior
appear
concentr
somewhat
around
prior
mean
line
figur
near
mean
dot
edg
bound
prior
howev
signal
weak
evid
timetrend
allow
model
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
uncertainti
epidem
curv
due
imperfect
test
alberta
canada
lefthand
side
panel
figur
e
present
impact
epidem
curv
degrad
sensit
constant
time
expect
misclassif
error
increas
uncertainti
epidem
curv
also
increas
underestim
incid
case
appar
later
epidem
number
rise
righthand
panel
figur
e
indic
expect
sensit
improv
time
green
line
true
epidem
curv
expect
flatter
observ
also
appear
observ
true
curv
may
well
fall
within
rang
confid
interv
around
observ
count
blue
line
sensit
decreas
time
brown
line
true
epidem
curv
expect
steeper
observ
either
scenario
undercount
case
nearli
factor
two
appar
incid
grow
day
march
may
almost
case
vs
observ
alarm
misdiagnos
patient
spread
infect
selfisol
perhap
neg
test
result
provid
fals
sens
secur
imposs
know
among
thousand
symptomat
person
test
around
time
per
day
tabl
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
lefthand
panel
figur
f
present
impact
epidem
curv
degrad
sn
constant
time
alberta
misclassif
error
increas
uncertainti
epidem
curv
also
increas
also
appar
shape
epidem
curv
especi
count
high
far
steeper
infer
assum
perfect
test
righthand
panel
figur
f
indic
sensit
improv
time
green
line
true
epidem
curv
expect
practic
indistinguish
observ
one
philadelphia
eg
within
random
variat
observ
count
repres
confid
interv
blue
line
comfort
seem
plausibl
scenario
improv
time
qualiti
test
identif
truli
infect
howev
sensit
decreas
time
brown
line
undercount
case
hundr
late
march
rule
concern
alberta
misdiagnos
patient
spread
infect
unimped
imposs
know
among
hundr
symptomat
person
test
late
march
tabl
examin
scenario
alberta
philadelphia
lack
sensit
test
seem
matter
far
less
observ
count
low
earli
epidem
gap
observ
adjust
count
grow
number
observ
case
increas
reinforc
import
earli
test
least
respect
describ
timecours
epidem
even
imperfect
technolog
goldstein
burstyn
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
given
current
uncertainti
accuraci
diagnost
assay
tri
learn
sensit
specif
use
timeseri
laboratori
test
time
trend
time
test
result
although
confid
typic
specif
exce
littl
learn
sensit
prior
posterior
howev
import
gener
lack
learn
sensit
occur
stronger
prior
preval
justifi
andor
pronounc
trend
preval
posit
test
therefor
encourag
everi
jurisdict
suitabl
data
attempt
gain
insight
accuraci
test
use
method
method
exist
simpler
cheaper
laboratori
clinic
valid
studi
howev
valid
studi
approach
like
one
illustr
burstyn
et
al
still
reliabl
mean
determin
accuraci
diagnost
test
know
sensit
specif
import
demonstr
uncertaintybia
analysi
impact
epidem
curv
optimist
assumpt
nearperfect
specif
reason
rang
sensit
observ
epidem
curv
may
bia
estim
effect
reproduct
number
r
e
magnitud
epidem
peak
unpredict
direct
may
also
implic
understand
proport
popul
nonsuscept
research
attempt
develop
pharmaceut
prophylaxi
ie
vaccin
combin
greater
number
peopl
recov
infect
insight
herd
threshold
import
resolv
current
futur
outbreak
calcul
basic
effect
reproduct
number
herd
threshold
depend
upon
accuraci
surveil
data
describ
epidem
curv
limit
approach
includ
dynam
natur
data
chang
daili
may
perfectli
align
time
due
batch
test
discrep
data
resolv
time
like
fewer
case
test
posit
epidem
curv
alberta
urgenc
current
situat
justifi
best
also
make
strong
ad
hoc
assumpt
breakpoint
segment
regress
timetrend
sensit
preval
assum
breakpoint
suitabl
trend
paramet
although
much
issu
base
analysi
need
consid
imperfect
specif
creat
fals
posit
albeint
nowher
near
magnitud
fals
neg
middl
outbreak
result
wast
resourc
ideal
circumst
employ
two
stage
test
highli
sensit
serolog
assay
posit
trigger
pcrbase
assay
thu
would
requir
two
sampl
per
individu
blood
np
swab
twostag
test
would
resolv
lot
uncertainti
specul
singl
pcr
test
combin
sign
symptom
inde
model
use
diagnosi
infecti
diseas
hiv
hepat
c
work
also
focus
valid
laboratori
test
sensit
specif
entir
process
identif
case
involv
select
test
via
procedur
design
induc
system
bias
rel
popul
conclud
paramount
import
valid
laboratori
test
share
knowledg
especi
epidem
matur
full
forc
insight
ascertain
bia
peopl
select
test
use
estim
epidem
curv
likewis
import
obtain
quantifi
quantif
sourc
misclassif
bia
lead
adjust
analys
epidem
curv
help
make
appropri
public
health
polici
author
report
conflict
interest
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
let
r
k
infect
preval
test
pool
day
correspond
kth
k
knot
let
sn
k
test
sensit
achiev
within
pool
without
ambigu
index
indic
tth
day
oppos
k
kth
k
knot
r
sn
preval
sensit
achiev
via
linear
interpol
straddl
knot
let
sp
test
specif
assum
constant
time
prior
preval
specifi
distribut
r
k
independ
uniform
compon
left
right
endpoint
compon
compris
hyperparamet
though
applic
reduc
singl
hyperparamet
specifi
common
upperbound
set
zero
common
lowerbound
prior
sensit
construct
take
sn
k
sn
k
w
sn
b
k
prior
specif
sn
k
via
independ
uniform
compon
hyperparamet
correspond
endpoint
second
compon
perfectli
linear
sn
sn
b
k
stochast
taken
independ
uniformli
distribut
use
endpoint
correspond
compon
sn
thu
prior
sn
structur
differ
hyperparamet
prior
r
w
increas
howev
time
trajectori
sn
becom
smoother
complet
specif
assign
prior
w
name
w
unif
thu
arbitrarili
dictat
trajectori
smooth
priori
note
also
applic
use
common
lower
upper
bound
sn
k
two
hyperparamet
need
defin
prior
r
sn
sp
specifi
model
observ
number
posit
test
tth
day
n
test
build
factor
form
bin
n
r
true
number
day
posit
ultim
paramet
interest
wherea
tth
observ
count
decompos
b
bin
sn
portion
observ
count
aris
true
posit
independ
b
bin
n
portion
aris
fals
posit
compris
complet
stochast
gener
model
henc
markov
chain
mont
carlo
sampl
joint
distribut
latent
quantiti
given
observ
quantiti
feasibl
latent
includ
w
sn
k
sn
sn
b
k
sp
r
k
observ
data
two
seri
n
elabor
underidentifi
natur
statist
problem
simplest
consid
case
case
observ
data
govern
e
n
r
sn
inde
ask
data
complet
distinguish
sn
r
imposs
least
absenc
prior
inform
piecewiselinear
assumpt
sn
r
valid
howev
one
might
anticip
partial
inform
come
forward
consid
singl
interv
two
knot
data
signal
interv
happen
highli
linear
sever
pauciti
inform
two
coeffici
describ
composit
signal
ask
inform
four
coeffici
describ
two
constitu
signal
albeit
help
prior
bound
constitu
signal
hand
data
signal
happen
quadrat
still
face
underidentifi
situat
least
three
piec
inform
composit
signal
partial
inform
four
descriptor
constitu
quantiti
march
data
provinc
alberta
canada
limit
presum
complet
data
littl
affect
lag
test
result
diagnosi
figur
e
librari
plotrix
number
case
observ
c
cstr
c
length
cstr
timeinvari
sn
lefthand
side
figur
e
observ
epi
curv
day
rep
confid
interv
observ
count
poisson
distribut
http
li
qchisq
cstr
ui
qchisq
plotci
xday
ycstr
lili
uiui
col
blue
ylimc
xlimc
ylab
predict
true
case
c
xlab
presum
date
onset
march
use
http
calcul
select
param
beta
dist
sn
adjust
epi
curv
mc
sensit
analysi
number
mc
simul
c
sim
snrbeta
ycstrsn
line
day
col
black
rm
sn
c
sim
snrbeta
ycstrsn
line
day
col
lightgrey
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
line
day
col
green
rm
sn
sn
decreas
c
sim
snc
ycstrsn
line
day
col
brown
rm
sn
legend
legendc
observ
c
ci
sn
increas
breakpoint
sn
decreas
breakpoint
breakpoint
colc
blue
green
brown
black
ltyc
lwdc
bg
ivori
bti
grey
ablin
hseq
col
gray
ablin
vc
col
black
end
code
alberta
march
data
citi
philadelphia
usa
limit
presum
complet
data
littl
affect
lag
test
result
diagnosi
figur
f
librari
plotrix
number
case
observ
c
cstr
c
length
cstr
timeinvari
sn
lefthand
side
figur
f
observ
epi
curv
day
rep
confid
interv
observ
count
poisson
distribut
http
li
qchisq
cstr
ui
qchisq
plotci
xday
ycstr
lili
uiui
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
col
blue
ylimc
xlimc
ylab
predict
true
case
c
xlab
presum
date
onset
march
use
http
calcul
select
param
beta
dist
sn
adjust
epi
curv
mc
sensit
analysi
number
mc
simul
c
sim
snrbeta
ycstrsn
line
day
col
black
rm
sn
c
sim
snrbeta
ycstrsn
line
day
col
lightgrey
rm
sn
c
sim
snrbeta
ycstrsn
line
day
col
red
rm
sn
c
sim
snrbeta
ycstrsn
line
day
col
orang
rm
sn
legend
legendc
observ
c
ci
colc
blue
lightgrey
red
orang
black
ltyc
lwdc
bg
ivori
bti
grey
ablin
hseq
col
gray
timevari
sn
righthand
side
figur
f
observ
epi
curv
day
rep
number
simul
realiz
plot
confid
interv
observ
count
poisson
distribut
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
